Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...
A new consensus by a team of experts in China has been established to guide researchers in evaluating the percutaneous absorption of cosmetic functional ingredients using in vitro diffusion cell ...
The in vitro assays from CN-Bio are effective in predicting clinical outcomes. High-functioning, metabolically competent human single- and multi-organ models are used in studies on drug metabolism, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback